MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

Search

Moleculin Biotech Inc

Geschlossen

4.12 2.74

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.01

Max

4.2

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+497.79% upside

Moleculin Biotech Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Jan. 2026, 23:08 UTC

Akquisitionen, Fusionen, Übernahmen

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

8. Jan. 2026, 21:39 UTC

Akquisitionen, Fusionen, Übernahmen

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

8. Jan. 2026, 20:54 UTC

Akquisitionen, Fusionen, Übernahmen

Glencore, Rio Tinto Restart Merger Talks -- Update

8. Jan. 2026, 20:44 UTC

Akquisitionen, Fusionen, Übernahmen

Glencore, Rio Tinto Restart Merger Talks

8. Jan. 2026, 17:05 UTC

Akquisitionen, Fusionen, Übernahmen

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

8. Jan. 2026, 16:43 UTC

Wichtige Markttreiber

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

8. Jan. 2026, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

8. Jan. 2026, 23:37 UTC

Market Talk

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

8. Jan. 2026, 22:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. Jan. 2026, 22:42 UTC

Market Talk

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

8. Jan. 2026, 22:30 UTC

Akquisitionen, Fusionen, Übernahmen

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

8. Jan. 2026, 21:53 UTC

Ergebnisse

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. Jan. 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8. Jan. 2026, 21:10 UTC

Akquisitionen, Fusionen, Übernahmen

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

8. Jan. 2026, 21:09 UTC

Market Talk

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

8. Jan. 2026, 21:09 UTC

Akquisitionen, Fusionen, Übernahmen

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

8. Jan. 2026, 20:21 UTC

Market Talk

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

8. Jan. 2026, 19:44 UTC

Market Talk

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

8. Jan. 2026, 18:50 UTC

Market Talk

Mexico's Industrial Production Seen Lower in November -- Market Talk

8. Jan. 2026, 17:48 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8. Jan. 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. Jan. 2026, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8. Jan. 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

8. Jan. 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. Jan. 2026, 16:45 UTC

Market Talk

Goldman Lifts 1H LME Copper Forecast -- Market Talk

8. Jan. 2026, 16:03 UTC

Market Talk

Global Equities Roundup: Market Talk

8. Jan. 2026, 16:03 UTC

Market Talk

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

8. Jan. 2026, 16:02 UTC

Market Talk

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

8. Jan. 2026, 15:23 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Defends Its Hostile Bid for Warner -- Update

Peer-Vergleich

Kursveränderung

Moleculin Biotech Inc Prognose

Kursziel

By TipRanks

497.79% Vorteil

12-Monats-Prognose

Durchschnitt 24.33 USD  497.79%

Hoch 31 USD

Tief 20 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Moleculin Biotech Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

3 ratings

3

Buy

0

Halten

0

Sell

Finanzen

$

help-icon Live chat